InsiderTrades

Form 4 for RLMD RELMADA THERAPEUTICS, INC.

Accepted 2024-01-31 00:00:00 ET · period of report 2024-01-29 · accession 0001213900-24-008557 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-01-31 2024-01-29+ RLMD Ence Chuck CA, CO P - Purchase $3.87 +39.0K 10.8K New +$150.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-31 P A 13,670 $4.05 38,970 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F4) Purchase prices range from $3.93 to $4.17 per share, inclusive.
2 Common Common Stock 2024-01-30 P A 14,500 $3.87 25,300 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F3) Purchase prices range from $3.755 to $3.99 per share, inclusive.
3 Common Common Stock 2024-01-29 P A 10,800 $3.65 10,800 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F2) Purchase prices range from $3.585 to $3.73 per share, inclusive.